Journal of Antivirals & Antiretrovirals

Journal of Antivirals & Antiretrovirals
Open Access

ISSN: 1948-5964

Journal of Antivirals & Antiretrovirals : Citations & Metrics Report

Articles published in Journal of Antivirals & Antiretrovirals have been cited by esteemed scholars and scientists all around the world. Journal of Antivirals & Antiretrovirals has got h-index 22, which means every article in Journal of Antivirals & Antiretrovirals has got 22 average citations.

Following are the list of articles that have cited the articles published in Journal of Antivirals & Antiretrovirals.

  2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Total published articles

58 57 32 59 77 13 11 20 37 22 37 55 22 12

Research, Review articles and Editorials

1 0 5 42 32 12 10 14 27 21 33 44 21 10

Research communications, Review communications, Editorial communications, Case reports and Commentary

48 57 27 17 45 1 1 6 10 1 4 11 1 2

Conference proceedings

0 0 0 0 0 0 35 51 125 100 191 0 125 177

Citations received as per Google Scholar, other indexing platforms and portals

98 160 172 269 223 172 219 195 170 116 60 36 26 58
Journal total citations count 2004
Journal impact factor 5.32
Journal 5 years impact factor 5.62
Journal cite score 5.3
Journal h-index 22
Journal h-index since 2019 17
Important citations (1101)

hart ta, willis ac, simpson sh, julien re, hoe d, et al. (2016) gay poz sex: a sexual health promotion intervention for hiv-positive gay and bisexual men. cognitive and behavioral practice. 23: 517-529.

ganjhu rk, mudgal pp, maity h, dowarha d, devadiga s, et al. (2015) herbal plants and plant preparations as remedial approach for viral diseases. virusdisease. 2015 dec 26: 225-236.

chea m, abjorensen s (2011) public health and hiv/aids in cambodia.

maphanga c, ombinda-lemboumba s, manoto s, maaza m, mthunzi-kufa p (2017) targeted femtosecond laser driven drug delivery within hiv-1 infected cells: in-vitro studies. inproc of spie 10062: 1006205-1006211.

leblanc n (2011) provider’s perceptions of couples hiv counseling and testing in south florida: a qualitative study.

lusvarghi s, bewley ca (2016) griffithsin: an antiviral lectin with outstanding therapeutic potential. viruses 8: 296.

mujahid m, ghani f (2011) research & reviews: journal of medical and health sciences. aids 54: 55.

bourguet‐kondracki ml, kornprobst jm (2014) promising marine molecules in pharmacology. outstanding marine molecules: chemistry, biology, analysis 243-264.

gordts sc, férir g, d’huys t, petrova mi, lebeer s, et al. (2015) the low-cost compound lignosulfonic acid (la) exhibits broad-spectrum anti-hiv and anti-hsv activity and has potential for microbicidal applications. plos one 10: e0131219.

férir g, gordts sc, schols d (2014) hiv-1 and its resistance to peptidic carbohydrate-binding agents (cbas): an overview. molecules. 19: 21085-21112.

férir g, huskens d, noppen s, koharudin lm, gronenborn am, et al. (2014) broad anti-hiv activity of the oscillatoria agardhii agglutinin homologue lectin family. journal of antimicrobial chemotherapy 25: dku220.

férir g, petrova mi, andrei g, huskens d, hoorelbeke b, et al. (2013) the lantibiotic peptide labyrinthopeptin a1 demonstrates broad anti-hiv and anti-hsv activity with potential for microbicidal applications. plos one 8: e64010.

galindo j, amariles p, mueses-marín hf, hincapié ja, gonzález-avendaño s, (2016) effectiveness and safety of generic version of abacavir/lamivudine and efavirenz in treatment naïve hiv-infected patients: a nonrandomized, open-label, phase iv study in cali-colombia, 2011–2012. bmc infectious diseases. 16: 532.

aïssi ak, fah l, akpovi cd, klotoé jr, dougnon vt, et al. (2014) impact of simultaneous exposure to lead and efavirenz on some biochemical markers in wistar rats. journal of environmental & analytical toxicology 4: 1.

quercia r, roberts j, martin-carpenter l, zala c (2015) comparative changes of lipid levels in treatment-naive, hiv-1-infected adults treated with dolutegravir vs. efavirenz, raltegravir, and ritonavir-boosted darunavir-based regimens over 48 weeks. clinical drug investigation 35: 211-219.

capel malo e, martínez de la sierra má, villaverde corrales a (2011) evolution of the human immunodeficiency virus type i protease and integrase.

malo ec (2011) evolution of the human immunodeficiency virus type i protease and integrase: effects on viral replication capacity and robustness.

pradesh a (2010) transplantation technologies & research.

kumar s, sayal p, budhani d, kumar s (2016) seropositivity of hepatitis b surface antigen in tertiary care centre: issues & considerations. international journal of medical research and review 30: 4-10.

wang w, shi ye, bai g, tang y, yuan y, et al. (2016) hbxag suppresses apoptosis of human placental trophoblastic cell lines via activation of the pi3k/akt pathway. cell biology international 40: 708-715.

Top